Download PDF
Ultraschall Med 2020; 41(05): 560-561
DOI: 10.1055/a-0770-5209
Letter to the Editor

Increased Cell-Free Fetal DNA Fraction in the First Trimester: A Sign of Abnormally Invasive Placenta?

Dagmar Wertaschnigg
1   Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, Salzburg, Austria
,
Miha Lucovnik
2   Department of Perinatology, University-Medical-Centre Ljubljana, Ljubljana, Slovenia
,
Eckhard Klieser
3   Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria
,
Judith Huber-Katamay
1   Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, Salzburg, Austria
,
Manfred Georg Moertl
4   Department of Obstetrics and Gynecology, Tertiary care center for Perinatology, Medical Center, Klagenfurt, Klagenfurt, Austria
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abnormally invasive placenta (AIP) is one of the most dangerous conditions associated with pregnancy, because it may cause severe peripartum hemorrhage resulting in acute maternal morbidity (i. e., due to the need for multiple blood transfusions, hysterectomy, uterine artery embolization, uterine balloon or uterine compression sutures or transfer to ICU) [1].



Publication History

Article published online:
05 November 2018

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Silver RM. et al. Placenta Accreta Spectrum. N Engl J Med 2018; 378: 1529-1536
    CrossrefPubMedGoogle Scholar
  • 2 Collins SL. et al. European Working Group on Abnormally Invasive Placenta (EW-AIP). Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol 2016; 47: 271-275
    CrossrefPubMedGoogle Scholar
  • 3 Gil MM. et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet. Gynecol 2015; 45: 249-266
    PubMedGoogle Scholar
  • 4 Taglauer ES. et al. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta 2014; 35: S64-S68
    CrossrefPubMedGoogle Scholar
  • 5 Wang E. et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn 2013; 33: 662-666
    CrossrefPubMedGoogle Scholar
  • 6 Levine RJ. et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of pre-eclampsia. Am J Obstet Gynecol 2004; 190: 707-713
    CrossrefPubMedGoogle Scholar
  • 7 Al Nakib M. et al. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther 2009; 26: 24-28
    CrossrefPubMedGoogle Scholar
  • 8 Farina A. et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005; 193: 421-425
    CrossrefPubMedGoogle Scholar
  • 9 Sekizawa A. et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002; 48: 353-354
    CrossrefPubMedGoogle Scholar
  • 10 Samuel A. et al. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study. Prenat Diagn 2013; 33: 1050-1053
    CrossrefPubMedGoogle Scholar